The global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters was estimated to be worth US$ 1059.5 million in 2023 and is forecast to a readjusted size of US$ 1317.8 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market

A balloon catheter is a type of "soft" catheter with an inflatable "balloon" at its tip which is used during a catheterization procedure to enlarge a narrow opening or passage within the body. The deflated balloon catheter is positioned, then inflated to perform the necessary procedure, and deflated again in order to be removed. The PTCA balloon catheter is inflated inside the narrowed part of the blood vessel to open up the blood vessel from the inside.

PTCA Balloon Catheter industry is relatively concentrated, the sales market share of North America, Europe, and Asia Pacific is covered 26.81%, 25.16% and 38.03%, respectively. APAC region is growing at the highest CAGR recent years. In 2020, the global sˌ

Report Scope

This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters by region & country, by Type, and by Application.

The Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters.

Market Segmentation

Scope of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market Report

Report Metric	Details
Report Name	Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market
Forecasted market size in 2030	US$ 1317.8 million
CAGR	3.1%
Forecasted years	2024 - 2030
Segment by Type:	Normal Balloon Catheter Drug Eluting Balloon Catheter Cutting Balloon Catheter Scoring Balloon Catheter
Segment by Application	Semi-Compliant Non-Compliant
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, B. Braun Melsungen AG, Biotronik Se & Co. Kg, Boston Scientific Corporation, C. R. Bard, Cardinal Health, Medtronic, MicroPort Scientific Corporation, Terumo Corporation, Spectranetics Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market size in 2030?

Ans: The Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market size in 2030 will be US$ 1317.8 million.

Who are the main players in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market report?

Ans: The main players in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik Se & Co. Kg, Boston Scientific Corporation, C. R. Bard, Cardinal Health, Medtronic, MicroPort Scientific Corporation, Terumo Corporation, Spectranetics Corporation

What are the Application segmentation covered in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market report?

Ans: The Applications covered in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market report are Semi-Compliant, Non-Compliant

What are the Type segmentation covered in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market report?

Ans: The Types covered in the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Market report are Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter

1 Market Overview

1.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Product Introduction

1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Size Forecast

1.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Trends & Drivers

1.3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Trends

1.3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Drivers & Opportunity

1.3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Challenges

1.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Players Revenue Ranking (2023)

2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue by Company (2019-2024)

2.3 Key Companies Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Manufacturing Base Distribution and Headquarters

2.4 Key Companies Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Product Offered

2.5 Key Companies Time to Begin Mass Production of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters

2.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Competitive Analysis

2.6.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Normal Balloon Catheter

3.1.2 Drug Eluting Balloon Catheter

3.1.3 Cutting Balloon Catheter

3.1.4 Scoring Balloon Catheter

3.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type

3.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, by Type (2019-2030)

3.2.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Semi-Compliant

4.1.2 Non-Compliant

4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application

4.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, by Application (2019-2030)

4.2.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region

5.1.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2019-2024)

5.1.3 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2025-2030)

5.1.4 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

5.2.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

5.3.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

5.4.2 Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

5.5.2 South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

5.6.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value

6.3 United States

6.3.1 United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.3.2 United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.4.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.5.2 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.5.3 China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.6.2 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.7.2 South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.8.2 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019-2030

6.9.2 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

6.9.3 India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Profile

7.1.2 Abbott Laboratories Main Business

7.1.3 Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.1.4 Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Laboratories Recent Developments

7.2 B. Braun Melsungen AG

7.2.1 B. Braun Melsungen AG Profile

7.2.2 B. Braun Melsungen AG Main Business

7.2.3 B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.2.4 B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.2.5 B. Braun Melsungen AG Recent Developments

7.3 Biotronik Se & Co. Kg

7.3.1 Biotronik Se & Co. Kg Profile

7.3.2 Biotronik Se & Co. Kg Main Business

7.3.3 Biotronik Se & Co. Kg Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.3.4 Biotronik Se & Co. Kg Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.3.5 Boston Scientific Corporation Recent Developments

7.4 Boston Scientific Corporation

7.4.1 Boston Scientific Corporation Profile

7.4.2 Boston Scientific Corporation Main Business

7.4.3 Boston Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.4.4 Boston Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.4.5 Boston Scientific Corporation Recent Developments

7.5 C. R. Bard

7.5.1 C. R. Bard Profile

7.5.2 C. R. Bard Main Business

7.5.3 C. R. Bard Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.5.4 C. R. Bard Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.5.5 C. R. Bard Recent Developments

7.6 Cardinal Health

7.6.1 Cardinal Health Profile

7.6.2 Cardinal Health Main Business

7.6.3 Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.6.4 Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.6.5 Cardinal Health Recent Developments

7.7 Medtronic

7.7.1 Medtronic Profile

7.7.2 Medtronic Main Business

7.7.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.7.4 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.7.5 Medtronic Recent Developments

7.8 MicroPort Scientific Corporation

7.8.1 MicroPort Scientific Corporation Profile

7.8.2 MicroPort Scientific Corporation Main Business

7.8.3 MicroPort Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.8.4 MicroPort Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.8.5 MicroPort Scientific Corporation Recent Developments

7.9 Terumo Corporation

7.9.1 Terumo Corporation Profile

7.9.2 Terumo Corporation Main Business

7.9.3 Terumo Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.9.4 Terumo Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.9.5 Terumo Corporation Recent Developments

7.10 Spectranetics Corporation

7.10.1 Spectranetics Corporation Profile

7.10.2 Spectranetics Corporation Main Business

7.10.3 Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

7.10.4 Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue (US$ Million) & (2019-2024)

7.10.5 Spectranetics Corporation Recent Developments

8 Industry Chain Analysis

8.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industrial Chain

8.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Model

8.5.2 Sales Channel

8.5.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

B Braun Melsungen AG

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

C R Bard

Cardinal Health

Medtronic Inc

Microport Scientific Corporation

Terumo Corporation

Spectranetics Corporation

List of Tables

Table 1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Trends

Table 2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Drivers & Opportunity

Table 3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Challenges

Table 4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Restraints

Table 5. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Product Type

Table 9. Key Companies Time to Begin Mass Production of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters

Table 10. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2019-2024) & (%)

Table 27. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Laboratories Basic Information List

Table 32. Abbott Laboratories Description and Business Overview

Table 33. Abbott Laboratories Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 34. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Abbott Laboratories (2019-2024)

Table 35. Abbott Laboratories Recent Developments

Table 36. B. Braun Melsungen AG Basic Information List

Table 37. B. Braun Melsungen AG Description and Business Overview

Table 38. B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 39. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of B. Braun Melsungen AG (2019-2024)

Table 40. B. Braun Melsungen AG Recent Developments

Table 41. Biotronik Se & Co. Kg Basic Information List

Table 42. Biotronik Se & Co. Kg Description and Business Overview

Table 43. Biotronik Se & Co. Kg Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 44. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Biotronik Se & Co. Kg (2019-2024)

Table 45. Biotronik Se & Co. Kg Recent Developments

Table 46. Boston Scientific Corporation Basic Information List

Table 47. Boston Scientific Corporation Description and Business Overview

Table 48. Boston Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 49. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Boston Scientific Corporation (2019-2024)

Table 50. Boston Scientific Corporation Recent Developments

Table 51. C. R. Bard Basic Information List

Table 52. C. R. Bard Description and Business Overview

Table 53. C. R. Bard Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 54. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of C. R. Bard (2019-2024)

Table 55. C. R. Bard Recent Developments

Table 56. Cardinal Health Basic Information List

Table 57. Cardinal Health Description and Business Overview

Table 58. Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 59. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Cardinal Health (2019-2024)

Table 60. Cardinal Health Recent Developments

Table 61. Medtronic Basic Information List

Table 62. Medtronic Description and Business Overview

Table 63. Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 64. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Medtronic (2019-2024)

Table 65. Medtronic Recent Developments

Table 66. MicroPort Scientific Corporation Basic Information List

Table 67. MicroPort Scientific Corporation Description and Business Overview

Table 68. MicroPort Scientific Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 69. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of MicroPort Scientific Corporation (2019-2024)

Table 70. MicroPort Scientific Corporation Recent Developments

Table 71. Terumo Corporation Basic Information List

Table 72. Terumo Corporation Description and Business Overview

Table 73. Terumo Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 74. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Terumo Corporation (2019-2024)

Table 75. Terumo Corporation Recent Developments

Table 76. Spectranetics Corporation Basic Information List

Table 77. Spectranetics Corporation Description and Business Overview

Table 78. Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Products, Services and Solutions

Table 79. Revenue (US$ Million) in Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Business of Spectranetics Corporation (2019-2024)

Table 80. Spectranetics Corporation Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Downstream Customers

Table 84. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Product Picture

Figure 2. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Report Years Considered

Figure 5. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Revenue in 2023

Figure 7. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Normal Balloon Catheter Picture

Figure 9. Drug Eluting Balloon Catheter Picture

Figure 10. Cutting Balloon Catheter Picture

Figure 11. Scoring Balloon Catheter Picture

Figure 12. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Semi-Compliant

Figure 15. Product Picture of Non-Compliant

Figure 16. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value (%), (2019-2030)

Figure 29. United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 35. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 37. China Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 47. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Type (%), 2023 VS 2030

Figure 49. India Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Sales Value by Application (%), 2023 VS 2030

Figure 50. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industrial Chain

Figure 51. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions